Cited by 346Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study

Myers, R. H., Schaefer, E. J., Wilson, P.W.F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A., Wolf, P. A.·1996·Neurology

DOI 10.1212/wnl.46.3.673

Open this paper in CoChat — free account

Abstract

Apolipoprotein E type 4 allele (apoE epsilon4) is associated with Alzheimer's disease (AD) in the late-onset familial form and in sporadic cases, but the age-associated risk in a randomly sampled elderly population is not established. We examined the association of apoE epsilon4 with AD and other dementias (mainly multi-infarct or dementia following stroke) in 1,030 persons aged 71 to 100 years in the population-based Framingham Study cohort. Kaplan-Meier survival analysis revealed that 55% of the apoE epsilon4/epsilon4 homozygotes developed AD by age 80, whereas 27% of apoE epsilon3/epsilon4 heterozygotes developed AD by age 85, and 9% of those without a 4 allele developed AD by age 85 years. In comparison with persons without a 4 allele, the risk ration for AD was 3.7 (95% CI = 1.9 to 7.5) for apoE epsilon3/epsilon4 heterozygotes and 30.1 (95% CI = 10.7 to 84.4) for apoE epsilon4 homozygotes. ApoE epsilon2 (2/2, 2/3, or 2/4 genotypes) was associated with an absence of AD. One-half (n=21) of the 43 AD patients were either homozygous or heterozygous for apoE epsilon4. We found evidence for an association of apoE epsilon4 with other dementia, primarily multi-infarct dementia and stroke. The risk ratio was 2.3 (95% CI = 0.9 to 6.1) for non-AD dementias among persons with apoE epsilon3/epsilon4. Although the apoE epsilon4 allele is a potent risk factor for AD and may be associated with other forms of dementia, most apoE epsilon4 carriers do not develop dementia, and about one-ha…

Integrity signals

Registry

Crossref · 10.1212/wnl.46.3.673

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Cyclic guanosine monophosphate as a mediator of vasodilation.
Murad, F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112536 · Cited by 799
Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.
(1991) · Europe PMC (PubMed Central) · Cited by 758
Neurosurgical horizons in Parkinson's disease
Goetz, C. G., Long, M. R. D., Penn, R. D., & Bakay, R. A. E. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.1 · Cited by 405
Megadose corticosteroids in multiple sclerosis
Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G. C., McFarland, H., Johnson, K., Reingold, S. C., & Whitaker, J. N. (1994) · Neurology · doi:10.1212/wnl.44.1.1 · Cited by 386
Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality
Ross, D. A., Dollimore, N., Smith, P. G., Kirkwood, B. R., Arthur, P., Morris, S. S., Addy, H. A., Binka, F., Arthur, P., Gyapong, J. O., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91879-q · Cited by 384

Show all 30 references

Research works printed but not linked: 12

Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein element 4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotype with late-onset Alzheimer's disease: population-based study. BMJ 1994;309:636-638.
Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993;43:515-519.
Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
Utterman G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-440.
10.1016/0140-6736(93)91879-Q · DOI
10.1016/0140-6736(93)91878-P · DOI
Myers RH Schaefer EJ Wilson PWF et al. Apolipoprotein E allele 4 is associated with dementia in the Framingham Study. In: Iqbal K Mortimer J Winblad B Wisniewski H eds. Research advances in Alzheimer's disease and related disorders. John Wiley & Sons Ltd. Chichester England: 1995:63-70.
van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E2 allele is associated with an increased risk of earlyonset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-610.
St. Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A. Apolipoprotein E element 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994;176:45-46.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
10.1212/WNL.45.1.1 · DOI

Sorted by citations

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Self-citation
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,271
Clinical Neurology and Epidemiology of the Major Neurodegenerative DiseasesPreprint
Erkkinen, M. G., Kim, M., & Geschwind, M. D. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,231
Dementia and Alzheimer Disease Incidence: A Prospective Cohort Study
Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714
Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study
Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1545 · Cited by 686
Self-citation
Depressive symptoms, cognitive decline, and risk of AD in older persons
Wilson, R. S., Barnes, L. L., Mendes de Leon, C. F., Aggarwal, N. T., Schneider, J. S., Bach, J., Pilat, J., Beckett, L. A., Arnold, S. E., Evans, D. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.3.364 · Cited by 528
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
The Role of <EMPH TYPE="ITAL">APOE</EMPH> ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons
Haan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 436
Self-citation
Epidemiology of Dementia and Alzheimer's Disease
Hendrie, H. C. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00002 · Cited by 411
Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women
Booth, S. L., Tucker, K. L., Chen, H., Hannan, M. T., GAGNON, D. R., Cupples, L. A., Wilson, P. W. F., Ordovás, J. M., Schaefer, E. J., Dawson‐Hughes, B., et al. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1201 · Cited by 404
Self-citation
Risk Estimates of Dementia by Apolipoprotein E Genotypes From a Population-Based Incidence Study: The Rotterdam Study
Slooter, A. J. C., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M. M. B., Van Broeckhoven, C., & van Duijn, C. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.964 · Cited by 399
Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Apolipoprotein E Polymorphism and Alzheimer Disease
Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 338
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study
van der Lee, S. J., Wolters, F. J., Ikram, M. K., Albert Hofman, D., Ikram, M. A., Amin, N., & van Duijn, C. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30053-x · Cited by 317
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?
Lautenschlager, N. T., Cupples, L. A., Rao, V. S., Auerbach, S. A., Becker, R., Burke, J., Chui, H., Duara, R., Foley, E. J., Glatt, S. L., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.641 · Cited by 298
Risk Factors for Dementia in the Cardiovascular Health Cognition Study
Kuller, L. H., López, O. L., Newman, A. B., Beauchamp, N. J., Burke, G. L., Dulberg, C. S., Fitzpatrick, A. L., Fried, L. P., & Haan, M. N. (2003) · Neuroepidemiology · doi:10.1159/000067109 · Cited by 296
Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., Cochran, E. J., Berry-Kravis, E., & Bienias, J. L. (2003) · Neurology · doi:10.1212/01.wnl.0000042478.08543.f7 · Cited by 282
Sleep Quality and 1-Year Incident Cognitive Impairment in Community-Dwelling Older Adults
Potvin, O., Lorrain, D., Forget, H., Dubé, M., Grenier, S., Préville, M., & Hudon, C. (2012) · SLEEP · doi:10.5665/sleep.1732 · Cited by 278
APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway
Sando, S. B., Melquist, S., Cannon, A., Hutton, M. L., Sletvold, O., Saltvedt, I., White, L. R., Lydersen, S., & Aasly, J. O. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-9 · Cited by 261
The role of APOE -ε4 in longitudinal cognitive decline
Bretsky, P., Guralnik, J. M., Launer, L. J., Albert, M., & Seeman, T. E. (2003) · Neurology · doi:10.1212/01.wnl.0000055875.26908.24 · Cited by 258
Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Knopman, D. S., Boeve, B. F., & Petersen, R. C. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.10.1290 · Cited by 257
Apolipoprotein E genotyping in Alzheimer's disease
Relkin, N. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90284-6 · Cited by 239
Questionable Dementia: Clinical Course and Predictors of Outcome
Devanand, D. P., Folz, M., Gorlyn, M., Moeller, J. R., & Stern, Y. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00947.x · Cited by 240
APOE Genotype Effects on Alzheimer's Disease Onset and Epidemiology
Ashford, J. W. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:157 · Cited by 239
Genetics of Alzheimer's Disease: A Centennial Review
Ertekin‐Taner, N. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.009 · Cited by 243
Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE
Wijsman, E. M., Pankratz, N., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., Lee, J. H., Bird, T. D., Bennett, D. A., Diaz-Arrastia, R. R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001308 · Cited by 229
APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
Uddin, M. S., Kabir, M. T., Al Mamun, A., Abdel-Daim, M. M., Barreto, G. E., & Ashraf, G. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1237-z · Cited by 212
Genetics of Alzheimer’s Disease
Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 220
APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Martins, C. A. R., Oulhaj, A., de Jager, C. A., & Williams, J. H. (2005) · Neurology · doi:10.1212/01.wnl.0000188871.74093.12 · Cited by 205
Prevalence of Alzheimer’s disease in very elderly people: A prospective neuropathological study
Polvikoski, T., Sulkava, R., Myllykangas, L., Notkola, I.-L., Niinistö, L., Verkkoniemi, A., Kainulainen, K., Kontula, K., Pérez–Tur, J., Hardy, J., et al. (2001) · Neurology · doi:10.1212/wnl.56.12.1690 · Cited by 197
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease
van Himbergen, T. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.670 · Cited by 202
The Apolipoprotein E ϵ4 Allele and Decline in Different Cognitive Systems During a 6-Year Period
Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., Berry‐Kravis, E., Bach, J., Fox, J. H., Evans, D. A., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.7.1154 · Cited by 192
Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II
López, O. L., Becker, J. T., Klunk, W. E., Saxton, J. A., Hamilton, R. L., Kaufer, D., Sweet, R. A., MELTZER, C. C., Wisniewski, S. R., Kamboh, M. I., et al. (2000) · Neurology · doi:10.1212/wnl.55.12.1863 · Cited by 188
Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study
Naj, A. C., Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. S., Beecham, G. W., Rajbhandary, R. A., Hamilton-Nelson, K. L., Wang, L.-S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1491 · Cited by 185
The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2
Suri, S., Heise, V., Trachtenberg, A. J., & Mackay, C. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.010 · Cited by 183
APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
O'Donoghue, M. C., Murphy, S. E., Zamboni, G., Nobre, A. C., & Mackay, C. E. (2018) · Cortex · doi:10.1016/j.cortex.2018.03.025 · Cited by 191
The Clinical Introduction of Genetic Testing for Alzheimer Disease An Ethical Perspective
Post, S. G. (1997) · JAMA · doi:10.1001/jama.277.10.832 · Cited by 204
Apolipoprotein E 4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Hsiung, G. R. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031789 · Cited by 163
The apolipoprotein E varepsilon2 allele and decline in episodic memory
Wilson, R. S. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.672 · Cited by 161
Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I
López, O. L., Becker, J. T., Klunk, W. E., Saxton, J. A., Hamilton, R. L., Kaufer, D., Sweet, R. A., MELTZER, C. C., Wisniewski, S. R., Kamboh, M. I., et al. (2000) · Neurology · doi:10.1212/wnl.55.12.1854 · Cited by 157
Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow, R. H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.021 · Cited by 154
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
Skoog, I. G., Hesse, C., Aevarsson, Ó., Landahl, S., Wahlström, J., Fredman, P., & Blennow, K. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.37 · Cited by 143
Dementia and Hip Fractures
Friedman, S. M., Menzies, I. B., Bukata, S. V., Mendelson, D. A., & Kates, S. L. (2010) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/2151458510389463 · Cited by 141
Interaction of Nascent ApoE2, ApoE3, and ApoE4 Isoforms Expressed in Mammalian Cells with Amyloid Peptide β (1−40). Relevance to Alzheimer's Disease
Aleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
Self-citation
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
Bickeböller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Pérez‐Tur, J., Michon, A., et al. (1997) · Europe PMC (PubMed Central) · Cited by 135
Dementia Care in 9 OECD Countries
Moïse, P., Schwarzinger, M., & Um, M. Y. (2004) · OECD health working papers · doi:10.1787/485700737071 · Cited by 131
Genome-wide Association Studies in Alzheimer’s Disease: A Review
Tosto, G., & Reitz, C. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0381-0 · Cited by 131
Cognitive Performance in Older Women Relative to ApoE-ε4 Genotype and Aerobic Fitness
ETNIER, J. L., CASELLI, R. J., REIMAN, E. M., ALEXANDER, G. E., SIBLEY, B. A., TESSIER, D., & MCLEMORE, E. C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000239399.85955.5e · Cited by 124
The “LEARn” (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial steps
Lahiri, D. K., & Maloney, B. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.001 · Cited by 124
The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
Zhang, X., Fu, Z., Meng, L., He, M., & Zhang, Z. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00359 · Cited by 127
APOE genotype and cognitive decline in a middle-aged cohort
Blair, C. K., Folsom, A. R., Knopman, D. S., Bray, M. S., Mosley, T. H., & Boerwinkle, E. (2005) · Neurology · doi:10.1212/01.wnl.0000149643.91367.8a · Cited by 143
Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities
Reitz, C. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002469 · Cited by 125
Predictive Utility of Apolipoprotein E Genotype for Alzheimer Disease in Outpatients With Mild Cognitive Impairment
Devanand, D. P., Pelton, G. H., Zamora, D., Liu, X., Tabert, M. H., Goodkind, M. S., Scarmeas, N., Braun, I. M., Stern, Y., & Mayeux, R. P. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.975 · Cited by 122
Apolipoprotein E epsilon 4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence
Jelić, V., Julin, P., Shigeta, M., Nordberg, A. K., Lannfelt, L., Winblad, B. G., & Wahlund, L. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.59 · Cited by 121
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Drzezga, A., Riemenschneider, M., Strassner, B., Grimmer, T., Peller, M., Knoll, A., Wagenpfeil, S., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148478.39691.d3 · Cited by 116
Midlife income, occupation, APOE status, and dementia
Anttila, T., Helkala, E.-L., Kivipelto, M., Hallikainen, M., Alhainen, K., Heinonen, H. S., Mannermaa, A., Tuomilehto, J. O., Soininen, H. S., & Nissinen, A. M. (2002) · Neurology · doi:10.1212/wnl.59.6.887 · Cited by 108
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
Ranson, J. M., Rittman, T., Hayat, S. A., Brayne, C., Jessen, F., Blennow, K., van Duijn, C. M., Barkhof, F., Tang, E. Y. H., Mummery, C. J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00895-4 · Cited by 123
Normal Genetic Variation, Cognition, and Aging
Greenwood, P. M., & Parasuraman, R. (2003) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582303260641 · Cited by 110
The Association between Apolipoprotein E and Traumatic Brain Injury Severity and Functional Outcome in a Rehabilitation Sample
Ponsford, J., McLaren, A., Schönberger, M., Burke, R., Rudzki, D., Olver, J., & Ponsford, M. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1623 · Cited by 103
Genetics of Alzheimer's Disease. A Rapidly Evolving Field
Serretti, A., Olgiati, P., & Ronchi, D. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12108 · Cited by 105
Stress-Induced Depression and Alzheimer’s Disease: Focus on Astrocytes
Dolotov, O. V., Inozemtseva, L. S., Myasoedov, N. F., & Grivennikov, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094999 · Cited by 104
Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis
Zhou, B., Teramukai, S., & Fukushima, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099037 · Cited by 99
Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish Brain Power initiative
Wang, H., Gustafson, D., Kivipelto, M., Pedersen, N. L., Skoog, I. G., Windblad, B., & Fratiglioni, L. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.003 · Cited by 104
Potential role of dietary n−3 fatty acids in the prevention of dementia and macular degeneration
Johnson, E. J., & Schaefer, E. J. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1494s · Cited by 97
Self-citation
The effects of APOE-ε4 on the BOLD response
Trachtenberg, A. J., Filippini, N., & Mackay, C. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.009 · Cited by 97
Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?
Bliwise, D. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00436-1 · Cited by 96
The role of apolipoprotein E in Alzheimer’s disease: pharmacogenomic target selection
Saunders, A. M., Trowers, M. K., Shimkets, R. A., Blakemore, S., Crowther, D., Mansfield, T. A., Wallace, D. M., Strittmatter, W. J., & Roses, A. D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00035-1 · Cited by 92
Statins for the prevention of Alzheimer's disease and dementia
Scott, H. D., & Laake, K. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160 · Cited by 91
Education and APOE-e4 in Longitudinal Cognitive Decline: MacArthur Studies of Successful Aging
Seeman, T. E., Huang, M.-H., Bretsky, P., Crimmins, E., Launer, L., & Guralnik, J. M. (2005) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/60.2.p74 · Cited by 88
Dementia in late-onset epilepsy
Johnson, E. L., Krauss, G. L., Kucharska‐Newton, A., Albert, M., Brandt, J., Walker, K. A., Yaşar, S., Knopman, D. S., Vossel, K. A., & Gottesman, R. F. (2020) · Neurology · doi:10.1212/wnl.0000000000011080 · Cited by 89
Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research
Yagi, T., Kosakai, A., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Nabetani, A., Ishikawa, F., Arai, Y., Hirose, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041572 · Cited by 84
That Obscure Object of Global Health
Fassin, D. (2012) · Duke University Press eBooks · doi:10.1215/9780822395478-007 · Cited by 87
A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics
Harwood, D. G., Barker, W. W., Loewenstein, D., Ownby, R. L., George‐Hyslop, P. S., MULLAN, M. J., & Duara, R. (1999) · Neurology · doi:10.1212/wnl.52.3.551 · Cited by 81
How can elderly apolipoprotein E ε4 carriers remain free from dementia?
Ferrari, C., Xu, W., Wang, H., Winblad, B. G., Sorbi, S., Qiu, C., & Fratiglioni, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.003 · Cited by 79
Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage
Woo, D., D, B. M. K. M., Khoury, J. C., Sauerbeck, L. R., Haverbusch, M. A., Szaflarski, J. P., Gebel, J., Pancioli, A., Jauch, E. C., Schneider, A. T., et al. (2004) · Stroke · doi:10.1161/01.str.0000127786.16612.a4 · Cited by 77
Postgenomics, uncertain futures, and the familiarization of susceptibility genes
Chilibeck, G., Lock, M. M., & Sehdev, M. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2010.01.053 · Cited by 74
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer
Zannis, V. I., Chroni, A., Kypreos, K. E., Kan, H.-Y., Cesar, T. B., Zanni, E. E., & Kardassis, D. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00008 · Cited by 74
Coronary Artery Calcium and Risk of Dementia in MESA (Multi-Ethnic Study of Atherosclerosis)
Fujiyoshi, A., Jacobs, D. R., Fitzpatrick, A. L., Alonso, Á., Duprez, D. A., Sharrett, A. R., Seeman, T. E., Blaha, M. J., Luchsinger, J. A., & Rapp, S. R. (2017) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.005349 · Cited by 73
APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer’s Disease Risk in a Multiracial Sample
Choi, K., Lee, J., Gunasekaran, T., Kang, S., Lee, W., Jeong, J., Lim, H., Zhang, X., Zhu, C., Won, S.-Y., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081236 · Cited by 72
Epigenetic signature and enhancer activity of the human APOE gene
Yu, C., Cudaback, E., Foraker, J. E., Thomson, Z., Leong, L., Lutz, F., Gill, J. A., Saxton, A. D., Kraemer, B. C., Navas, P. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt354 · Cited by 71
Successful Coping, Adaptation and Resilience in the Elderly: An Interpretation of Epidemiologic Data
Foster, J. R. (1997) · Psychiatric Quarterly · doi:10.1023/a:1025432106406 · Cited by 77
The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer's Diseasea
Relkin, N. R., Kwon, Y. J., Tsai, J., & Gandy, S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32608.x · Cited by 69
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
Payami, H., Grimslid, H., Oken, B., Camicioli, R. M., Sexton, G. J., Dame, A., Howieson, D. B., & Kaye, J. A. (1997) · PubMed · Cited by 66
CSF beta-amyloid, cognition, and APOE genotype in Alzheimer’s disease
Samuels, S., Silverman, J. M., Marin, D. B., Peskind, E. R., Younki, S. G., Greenberg, D. A., Schnur, E., Santoro, J., & Davis, K. L. (1999) · Neurology · doi:10.1212/wnl.52.3.547 · Cited by 67
Gene-Environment Interaction in Alzheimer’s Disease:A Potential Role for Cholesterol
Chandra, V., & Pandav, R. S. (1998) · Neuroepidemiology · doi:10.1159/000026175 · Cited by 66
Relation of Blood Pressure to Risk of Incident Alzheimer’s Disease and Change in Global Cognitive Function in Older Persons
Shah, R. C., Wilson, R. S., Bienias, J. L., Arvanitakis, Z., Evans, D. A., & Bennett, D. A. (2005) · Neuroepidemiology · doi:10.1159/000089235 · Cited by 64
Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran
Vaisi‐Raygani, A., Zahrai, M., Raygani, A. V., Doosti, M., Javadi, E., رضایی, م., & Pourmotabbed, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.073 · Cited by 64
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
Larson, I. A., Ordovás, J. M., DeLuca, C., Barnard, J. R., Feussner, G., & Schaefer, E. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00280-4 · Cited by 64
Self-citation
Apolipoprotein E Genotypes: Relationship to Cognitive Functioning, Cognitive Decline, and Survival in Nonagenarians
Bathum, L., Christiansen, L., Jeune, B., Vaupel, J. W., McGue, M. K., & Christensen, K. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53554.x · Cited by 63
Association of Apolipoprotein E Genotype and Cerebral Palsy in Children
Kuroda, M. M., Weck, M. E., Sarwark, J. F., Hamidullah, A., & Wainwright, M. S. (2007) · PEDIATRICS · doi:10.1542/peds.2006-1083 · Cited by 62
Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer Disease
Martinez, M. M., Campion, D., Brice, A., Hannequin, D., Dubois, B., Didierjean, O., Michon, A., Thomas-Antérion, C., Puel, M., Frébourg, T., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.6.810 · Cited by 63
Dementia in Taiwan: past, present, and future.
Fuh, J., & Wang, S. (2008) · PubMed · Cited by 62
Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study
Riley, K. P., Snowdon, D. A., Saunders, A. M., Roses, A. D., Mortimer, J. A., & Nanayakkara, N. (2000) · The Journals of Gerontology Series B · doi:10.1093/geronb/55.2.s69 · Cited by 63
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Shajith Anoop, S., Misra, A., Meena, K., & Luthra, K. (2010) · PubMed · Cited by 60
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
Aksman, L., Oxtoby, N. P., Scelsi, M. A., Wijeratne, P. A., Young, A. L., Alves, I. L., Collij, L. E., Vogel, J. W., Barkhof, F., Alexander, D. C., et al. (2023) · Brain · doi:10.1093/brain/awad232 · Cited by 69

Authors: Myers, R. H., Schaefer, E. J., Wilson, P. W. F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A., & Wolf, P. A.
Affiliations: Boston University (US)
ORCID: Myers, R. H.
Schaefer, E. J.
Wilson, P.W.F.
Au, R.
White, R. F.
Knoefel, J. E.
Beiser, A.
Wolf, P. A.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1996-03
Volume: 46
Issue: 3
Pages: 673-677
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.46.3.673
OpenAlex: W1972509050
Cited by: 346
References: 30
Citations by year: 2026: 2 · 2025: 6 · 2024: 1 · 2023: 4 · 2022: 10 · 2021: 12 · 2020: 5 · 2019: 10 · 2018: 8 · 2017: 6 · 2016: 6 · 2015: 13 · 2014: 11 · 2013: 16 · 2012: 24
FWCI: 16.71
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc038038-022)
National Institute on Aging (2-R01-AG08122-06, R01AG008122)
National Heart, Lung, and Blood Institute (N01-HC-38038)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: APOE ε4, Alzheimer's disease, dementia, multi-infarct dementia, stroke, genetic risk factors, APOE genotype, Framingham Heart Study, older adults, positive predictive value, genetic screening
MeSH terms: Adult, Aged, Aged, 80 and over, Alleles, Alzheimer Disease, Apolipoproteins E, Base Sequence, Dementia, Female, Humans, Longitudinal Studies, Male, Middle Aged, Molecular Sequence Data, Sensitivity and Specificity, Cohort Studies, Molecular Probes, Incidence, Odds Ratio, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks